These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21522029)

  • 1. Cell surface receptors in malignant glioma.
    Li YM; Hall WA
    Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular-targeted therapy for malignant glioma].
    Yamanaka R
    Brain Nerve; 2009 Feb; 61(2):177-88. PubMed ID: 19235468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging targeted treatments for malignant glioma.
    Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of EGFR in malignant gliomas.
    Ye F; Gao Q; Cai MJ
    Expert Opin Ther Targets; 2010 Mar; 14(3):303-16. PubMed ID: 20148717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly targeted therapies for malignant gliomas: advances and challenges.
    Penas-Prado M; Gilbert MR
    Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for malignant gliomas.
    Kreisl TN
    Semin Radiat Oncol; 2009 Jul; 19(3):150-4. PubMed ID: 19464629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New molecular targets in malignant gliomas.
    de Groot JF; Gilbert MR
    Curr Opin Neurol; 2007 Dec; 20(6):712-8. PubMed ID: 17992095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapies for malignant gliomas: a local affair?
    Rainov NG; Söling A; Heidecke V
    Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting malignant glioma survival signalling to improve clinical outcomes.
    Wong ML; Kaye AH; Hovens CM
    J Clin Neurosci; 2007 Apr; 14(4):301-8. PubMed ID: 17276069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
    Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
    Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted therapy for malignant glioma.
    Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
    Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
    Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
    Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery: targeted toxin treatment of malignant glioma.
    Hall WA; Sherr GT
    Neurosurg Focus; 2006 Apr; 20(4):E10. PubMed ID: 16709015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New glioma therapy using specific microRNAs].
    Halle B; Andersen C; Schulz MK; Kristensen BW
    Ugeskr Laeger; 2012 Mar; 174(10):630-3. PubMed ID: 22395010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of adults with recurrent malignant glioma.
    Nabors LB; Fiveash J
    Expert Rev Neurother; 2005 Jul; 5(4):509-14. PubMed ID: 16026234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
    Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
    Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
    Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
    Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
    Karpel-Massler G; Schmidt U; Unterberg A; Halatsch ME
    Mol Cancer Res; 2009 Jul; 7(7):1000-12. PubMed ID: 19584260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tyrosine kinase inhibitors in the management of high-grade gliomas.
    Ahluwalia MS; Patel M; Peereboom DM
    Expert Rev Anticancer Ther; 2011 Nov; 11(11):1739-48. PubMed ID: 22050023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.